Search research articles
Contact Us
Filters
Showing results (121-130 of 862) with videos related to
Page
of 87
Sort By:
The International Journal of Neuropsychopharmacology
|
November 21, 2017
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
Yukihiko Shirayama, Kenji Hashimoto
Brain Research Bulletin
|
June 2, 2022
Special issue on "Brain-body communication in health and diseases"
Kenji Hashimoto, Chun Yang
International Journal of Molecular Sciences
|
May 14, 2022
Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders
Jiajing Shan, Kenji Hashimoto
Advances in Experimental Medicine and Biology
|
April 26, 2026
Rethinking the Treatment-Resistant Depression
Yunfei Tan, Kenji Hashimoto
Molecular Psychiatry
|
September 13, 2022
Comments to behavioral tests for antidepressant-like actions of (2R,6R)-hydroxynorketamine by Bonaventura et al
Lijia Chang, Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience
|
August 3, 2016
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
Yukihiko Shirayama, Kenji Hashimoto
Current Pharmaceutical Design
|
March 2, 2011
α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia
Masatomo Ishikawa, Kenji Hashimoto
Plos One
|
December 15, 2010
A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI
Kenji Hashimoto, Tamaki Ishima
Brain Tumor Pathology
|
August 12, 2011
Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult
Masayuki Shintaku, Kenji Hashimoto
International Journal of Geriatric Psychiatry
|
November 5, 2011
Sigma-1 receptor agonist fluvoxamine for delirium in older adults
Kenji Hashimoto, Tsutomu Furuse
Page
of 87
Search research articles
Search
Showing results (121-130 of 862) with videos related to
Sort By:
Page
of 87
The International Journal of Neuropsychopharmacology
|
November 21, 2017
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
Yukihiko Shirayama, Kenji Hashimoto
Brain Research Bulletin
|
June 2, 2022
Special issue on "Brain-body communication in health and diseases"
Kenji Hashimoto, Chun Yang
International Journal of Molecular Sciences
|
May 14, 2022
Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders
Jiajing Shan, Kenji Hashimoto
Advances in Experimental Medicine and Biology
|
April 26, 2026
Rethinking the Treatment-Resistant Depression
Yunfei Tan, Kenji Hashimoto
Molecular Psychiatry
|
September 13, 2022
Comments to behavioral tests for antidepressant-like actions of (2R,6R)-hydroxynorketamine by Bonaventura et al
Lijia Chang, Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience
|
August 3, 2016
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
Yukihiko Shirayama, Kenji Hashimoto
Current Pharmaceutical Design
|
March 2, 2011
α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia
Masatomo Ishikawa, Kenji Hashimoto
Plos One
|
December 15, 2010
A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI
Kenji Hashimoto, Tamaki Ishima
Brain Tumor Pathology
|
August 12, 2011
Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult
Masayuki Shintaku, Kenji Hashimoto
International Journal of Geriatric Psychiatry
|
November 5, 2011
Sigma-1 receptor agonist fluvoxamine for delirium in older adults
Kenji Hashimoto, Tsutomu Furuse
Page
of 87